(1583 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
The Evolving Evidence for the Long-Term, Prophylactic Treatment of Hereditary Angioedema Patients with Subcutaneous C1-INHWelcome and Introduction Marcus Maurer ...
-
Exploring the Complexity of Chronic Spontaneous UrticariaChronic Spontaneous Urticaria (CSU): unpredictable, chronic and burdensome ...
-
Asthma, does allergy matter?Welcome and introduction/1 Pablo Rodrígue...
-
Advances in eosinophilic diseases
-
Chronic spontaneous urticaria: defining the pathway to successful managementWelcome and Introduction Marcus Maurer ...
-
Childhood Asthma and the Impact of Type 2 InflammationOpening Remarks The Burden of...
-
Autoimmunity and immune deficits in IEI – uncovering APDSWelcome and Introduction Diag...
-
Complete control of chronic spontaneous urticaria – mission (im)possible?
-
IgE in asthma and nasal polyposis: your questions answered
-
Navigating Type 2 Inflammation across the skin, airway, and esophagusNavigating Type 2 Inflammation across the skin, airway, and esophagus ...
-
Reconsider the art of AITWelcome and introduction Pati...
-
The Link between Early Diet and Food AllergyIntroduction Liam O’Mahony ...
-
Allergen composition of preparations translate into clinical outcomes of AITWelcome and introduction Suzanne Lau ...
-
Ameliorating atopy by targeted micronutrient supplementation with beta-lactoglobulinFranziska Roth-Walter
-
Mind the PAF: a new route to managing chronic urticaria and allergic diseases?Welcome address Frank Siebenhaar ...
-
A novel dual key solution to unlock the treatment of allergic rhinitisClinical challenges and management strategies in allergic rhinitis: where are we? ...
-
Improving patients’ journeys in food allergyWelcome and introduction Alexandra Santos ...
-
Type 2 Inflammation: What every clinician should knowHans In‘t Veen, Jasper Kappen This Company Sponsored Symposia...
-
MicroCrystalline Tyrosine-associated allergoids: Reaching the top of the evidence pyramidRalph Mösges
-
IgE-mediated food allergy: need for a revolutionPanel discussion: Why do we need to be concerned about food allergy? What is the role of I...
Show more Sponsored Symposia (18)Show Less-
-
Danger signs
-
How to improve outcomes
-
Hypersensitivity to antiepileptic drugs
-
Phenotypes and Endotypes
-
Asthma: phenotypes to endotypes
-
Current and future perspectives
-
Ligelizumab (anti-IgE) in chronic spontaneous urticaria
-
Impact of climate change on the immune system
-
New perspectives for anaphylaxis
-
Viral infection and asthma
-
Clinical manifestations of severe cutaneous adverse drug reaction
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Immune response to Corona virus infection
-
How to classify cutaneous manifestations of drug hypersensitivity
-
The role of infection in chronic spontaneous urticaria
-
Lung function testing
-
GINA Guidelines Update
-
Neuroimmunology and allergy
-
Asthma management during the COVID-19 pandemics
-
Novel pharamacological targets
-
Exercise: induced asthma and rhinitis
-
Algorithm for evaluation of cutaneous manifestations of drug hypersensitivities
-
Air pollution and allergy: call for action!
-
Impact of climate change on asthma exacerbations
-
Does pediatric asthma primarily depend on submicrone aerosol pollutants?
-
Autoimmunity in atopic diseases
-
Update on drug allergy
-
Therapies for multiple-tree nut allergies
-
Microbiota in immune-based therapies
-
Wild-fires, pollution, climate change and other threats
-
The brain, nose, immune axis
-
Probiotics and prebiotics: an on-going journey
-
Tackling anaphylaxis
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Hologenome and obesity
-
Tezepelumab (anti-TSLP) in asthma
-
Eosinophilic fasciitis, an unusual presentation
-
Asma e alergia em Angola
-
It looks like urticaria – but is it?
-
Phenotypes and endotypes of occupational allergy
-
Difficult to control asthma in children
-
Bronchiectasis and severe asthma
-
Mechanism and prevention of epicutaneous sensitization to food allergens
-
Covid-19 in "Allergy" journal
-
Exercise-induced urticaria and anaphylaxis
-
Big changes in asthma treatment : GINA 2019
-
Difficult to control asthma in adults
-
Immune modulation in local allergic rhinitis
-
Environmental epigenomics of allergy
-
Big Data Analysis: MetabolomicsView Presentation
-
Asma e alergia em pandemia
-
Lesson learned from the pathogenesis of SARS-COV2
-
Non-steroidal anti-inflammatory drugs exacerbated disease (NERD)
-
Preparing a grant: Dos and Don'ts
-
Allergenicity and IgE recognition of new Dau c 1 allergens from carrot
-
Flare-up phenomenon of Sars-CoV2 vaccine secondary to epicutaneous test with polyethylene glycol
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Delabelling adults
-
Desensitization in chemotherapy and biologics
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
Gaps in the management of food-induced anaphylaxis reactions at school
-
Severe Asthma and COVID-19
-
Differential diagnosis
-
Current status on prophylaxis in HAE
-
New insights in urticaria mechanisms
-
Is IgA a piece of the EoE puzzle?
-
Developing an adolescent and young adult allergy service
-
Social media and Allergies: how can we support our patients?
-
Measles infection causes immune amnesia
-
How to evaluate lung function? Hands-on plus lecture
-
Targeted approaches for asthma
-
New and clinically relevant contact allergens
-
A patient with an acute reaction: recognize, document and treat
-
Eosinophil ETosis, a cytolytic degranulation and diseases
-
Launch of the Biological guidelines
-
Drug reactions of the skin or Novel mechanisms of drug reactions
-
Immunotherapy in severe asthma (AIT)
-
Inflammatory biomarkers
-
AI models
-
A system biology and machine learning approach to childhood asthma
-
Late onset T2 asthma – a case study
-
What’s different about the adolescent brain?
-
The concept of AllergoOncology: understanding the potential of IgE Antibodies in cancer
-
Occupational respiratory allergy in food processing industries
-
Do adrenaline auto-injectors save lives?
-
Management of adverse reactions to biologics
-
Environment and Immunology StandUp TalksSpeakers ...
-
Epicutaneous immunotherapy for the treatment of food allergy: ready for the prime time?
-
Pediatric Covid-19 highlights published in PAI in 2020
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
Trichinella spiralis infection associated with chronic spontaneous urticaria - case series
-
Anti IL4/13 and IL33/TSLP
-
Innate trained immunity: An evolutionary perspective
-
Emerging evidence on the link between air pollution and COVID-19 (Pro & Con Session: Con)
-
Emerging evidence on the link between air pollution and COVID-19 (Pro & Con Session: Pro)
-
E-cigarettes: mechanistic link to lung injury
-
Tree nut allergy: path from national to global data
-
Psychological support to peanut allergic children and their families
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
The clinical clues and pitfalls in contact dermatitis
-
Risk assessment and active management of food allergy
-
Epithelial cell barrier and allergic diseases
-
Elderly asthma
-
AAAAI Practice Parameters
-
The underlying immunology of pruritus
-
Vaccines for older adults: benefits and limitations
-
Insight from translational research on oral tolerance induction through breast milk
-
AIT in the pediatric population
-
Personalised immunoinflammatory phenotypes of children with acute viral bronchiolitis
-
Primary care in CRDs during COVID
-
Molecular immune biomarkers for protein-based and peptide immunotherapy
-
Is Patch Testing Valuable In Orofacial Granulomatosis/Granulomatous Cheilitis?
-
What is the immunological basis for new biologicals?
-
A cohort study into intravenous drug provocation tests in perioperative allergy
-
Molecular allergology in daily clinical practice
-
AIT, Biologicals and Covid vaccination
-
Dupilumab (anti-IL4Ra) in CRSwNP
-
Prevention and therapy in primary immunodeficiencies: Vaccination
-
Ligelizumab in adolescent patients with chronic spontaneous urticaria: results from a dedicated phase 2b study
-
B cell tolerance: an essential mechanism for allergen immunotherapy in house dust mite allergy
-
Metabolome-wide association study (MWAS) in subjects with self-reported beta-lactam allergic reactions using the twinsUK cohort
-
Pathophysiology and diagnostic innovation in ocular allergy
-
Update of the WAO anaphylaxis guidance
-
Gut microbiome and histamine signal in pathogenesis of IBD
-
Efficacy and safety of epicutaneous immunotherapy (EPIT) for peanut allergy in subjects with and without concomitant food allergies
-
Allergic severe asthma and cat epithelia in COVID-19 pandemic: a case report
-
Management of CRS: Highlights of EPOS 2020
-
Management of CRS: Highlights of EPOS 2020
-
Food industry perspective
-
Big data and cluster analysis: a real life perspective
-
Time for innovation: what can we learn from OMICs about asthma metabolic dysfunction?
-
Ligelizumab achieves high rate of complete response in patients with moderate to severe chronic spontaneous urticaria
-
Recognizing immediate reactions in contact dermatitis
-
Precision medicine in immunodeficiency
-
Sleep patterns and development of children with atopic dermatitis
-
Potential biomarkers for diagnosis and treatment for CSU
-
Vaccines- Is this the tool to end the pandemic?
-
Biological severe asthma treatment in Poland - pros and cons of drug programme
-
Is There A Place For Chlorhexidine In The European Baseline Series?
-
Allergy School Cork 2022 Abstract BookDownload Abstract Book
-
COVID-19 Vaccination: Separating facts from fiction for your patients
-
Age-related changes in innate immune response to in vitro rhinovirus infection in asthma patients
-
Cellular tests for the diagnosing and monitoring of allergy
-
Value of c-kit mutations in the skin, peripheral blood and bone marrow in pediatric mastocytosis. What does it tell us?
-
How can we improve the quality of life of patients with severe food allergy?
-
Precision Medicine and AIT
-
Immunological basis of food aversion
-
Basophil activation test in anaphylaxis to non-steroidal anti-inflammatory drugs – is it useful?
-
What do we learn from subgroup analyses in phase-III trials?
-
Telemedicine and Tele-health
-
EAACI Biologicals Guidelines – Recommendations for Severe Asthma
-
B cells in in chronic rhinosinusitis: friend or foe
-
Skin test, drug provocation and laboratory tests: which ones and when?
-
Understanding parent preferences for paediatric allergy services
-
EAACI Guidelines on environmental health
-
The ‘allergy tool kit’ for the transition clinic
-
Gut microbiome - based therapeutic approaches
-
Is anaphylaxis really rare in children?
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
Elevated tryptase – Now what?
-
Dupilumab suppresses serum total IgE levels across multiple atopic, allergic diseases
-
Human and computational models of immune mediated inflammatory skin disease: challenges, insights and perspectives
-
Precision medicine and biomarkers of atopic dermatitis
-
Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience
-
Electronic Health in Severe Asthma
-
MAIT cells are imprinted by the microbiota in early life and promote tissue repair
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Food allergy: new allergens on the block
-
Urban green spaces - The exposure and allergenicity index
-
The therapeutic and preventive effect of sublingual immunotherapy in mite-sensitized children with atopic dermatitis: A randomized, open, parallel-group study
-
How to select and follow a biological for asthma and CRSwNP
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Cow’s milk allergy can be monitored through the degree of competition between specific IgE and IgG
-
EAACI Guideline on NAR: does it need to be updated?
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
Updates in [severe] asthma in adults
-
Virtual care, social media and mHealth for allergy management
-
May contain traces… management in children with food allergies
-
Impaired olfaction: diagnostics and its role in diseases
-
Towards vaccination of birch pollen and birch pollen-associated food allergy
-
Efficacy of venom immunotherapy: How long should patients be treated?
-
Covid 19 and air pollution: is there a relationship?
-
Assessment of adherence to treatment using mHealth
-
Food allergy - the beginners guide
-
Challenges on the implementation of early introduction of allergenic foods
-
Distribution of ACE2, CD147, cyclophilins, CD26 and other SARS-CoV-2 associated molecules in human tissues and immune cells in health and disease
-
Structural biology of food allergens and cross reactivity
-
Air pollution-induced augmented allergenicity of Platanus hybrida pollen in urban environments
-
Evaluation of platelet to lymphocyte ratio (PLR) in various types of hypersensitivity to NSAIDs
-
Can group consultations work in allergy? Learning from rheumatology
-
Stratification of asthma phenotypes by airway proteomic signatures: A system biology approach
-
Oral food challenge versus biomarkers - are challenges still needed?
-
Hand eczema during the COVID-19 pandemic
-
Identification of optimal cut-off points for nasal volumes and symptoms score in the assessment of the outcome of the nasal allergen challenge
-
Molecular and structural considerations for aerosolization of food allergens
-
The trajectory of immune development in early life and its association with clinical allergic disease outcomes
-
Placeebo effect is an integrated part of the treatment of AIT (Pro & Con Session: Con)
-
Biomarkers and predictors of responses to biologicals in atopic dermatitis
-
Pru p 10: the polygalacturonase described as a new peach tree pollen allergen
-
Extreme prematurity strongly imprints circulating Natural Killer- and ?? T cells, which are further influenced by sepsis
-
Dupilumab improves asthma control and health-related quality of life in children with uncontrolled persistent asthma: VOYAGE study
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
Treating allergic patients during the COVID-19 pandemic
-
We are what we eat - importance of food to health, moving past simple calories
-
Metabolic changes in the prediction of severe anaphylactic reactions
-
Allergy to Kale
-
Airborne enzymes – New and re-emerging occupational hazards
-
Alternaria-induced thunderstorm asthma: An unrecognised trigger
-
NEK7-NLRP3 binding is essential in the assembly of NLRP3 inflammasome in the pathogenesis of house dust mite-induced asthma
-
When is it not a food allergy? Dietary approaches to the diagnosis of histamine intolerance
-
Role Viral reactivations
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Plans of GARD in terms of surveillance after COVID
-
Treatment with ligelizumab achieves over forty percent higher complete response rate in chronic spontaneous urticaria patients originally treated with omalizumab
-
Characterization of the immunological properties of different β-glucans on myeloid dendritic cells
-
Siblings and atopy by living standard, period, and atopy assessment method: a systematic review and meta-analysis
-
Avapritinib reduced cutaneous symptoms and mast cell (MC) burden in patients (pts) with indolent systemic mastocytosis (ISM) in the PIONEER study
-
The role of metalloproteinase 9 in the pathogenesis of atopic dermatitis in children
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Diagnosis of insect venom allergy: back to basics
-
Role of antigen-presenting cells in tolerance and allergy
-
Lessons learned from immune tolerance approaches to target allergic diseases: an NIAD’s perspective
-
Drug provocation test in non-immediate beta-lactam hypersensitivity workup: One-day vs prolonged protocol in pediatric patients
-
Diagnosis of NSAIDs-Exacerbated respiratory disease (N-ERD)
-
Implementing component resolved diagnostics in allergy diagnosis
-
Endotype-driven treatment in chronic rhinosinusitis
Show more Event Resources (224)Show Less-
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Current practice of allergy diagnosis and the potential impact of regulation in EuropeAbstract In the European Union (EU), the regulatory framework regarding diagnostic allerg...
-
Role of dietary fiber in promoting immune health - An EAACI position paperAbstract Microbial metabolism of specific dietary components, such as fiber, contributes ...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
Health effects of exposure to chlorination by - products in swimming poolsAbstract Concerns have been raised regarding the potential negative effects on human heal...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
Influenza burden, prevention, and treatment in asthma - A scoping review by the EAACI Influenza in asthma task forceAbstract To address uncertainties in the prevention and management of influenza in people...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paperAbstract Drug hypersensitivity reactions (DHR) constitute a major and common public healt...
-
The urgent need for a harmonized severity scoring system for acute allergic reactionsAbstract The accurate assessment and communication of the severity of acute allergic reac...
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task ForceAbstract Background: Guidelines for management of patients with allergic conditions are...
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperAbstract Introduction In allergic asthma patients, one of the more common phenotypes might...
-
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statementAbstract The vision of European Academy of Allergy and Clinical Immunology (EAACI) and th...
-
Hypersensitivity reactions to chemotherapy: an EAACI position paperAbstract Chemotherapeutic drugs have been widely used in the treatment of cancer disease ...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review - An EAACI position paperAbstract Drug hypersensitivity reactions (DHRs) are associated with high global morbidity...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)An ARIA-EAACI statement has been devised to make recommendations on asthma, and not necess...
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergyAbstract An accurate diagnosis of β-lactam (BL) allergy can reduce patient morbidity and...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence NetworkAllergy, Asthma and Clinical Immunology Research has many challenges, including complex Eu...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
Show more Position Papers (29)Show Less-
-
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsSARS‐CoV‐2 has triggered a pandemic that is now claiming many lives. Several studies h...
-
DGAKI statement on asthma and COVID-19AIT and COVID-19 March 18, 2020 Dear colleagues, In the past few days, we have received mo...
-
Risk factors for severe and critically ill COVID-19 patients: A reviewIntranasal corticosteroids remain the standard treatment for CRS in patients with SARS‐C...
-
First antibody trial launched in COVID-19 patientsThe article describes the initiation of the first clinical trial (ClinicalTrials.gov LY-Co...
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticariaThe COVID‐19 pandemic dramatically disrupts health care around the globe. The impact of ...
-
Multidisciplinary consensus on sputum induction biosafety during the COVID-19 pandemicSputum induction (SI) is the gold standard approach to the non‐invasive study of airway ...
-
Thirty‐six COVID‐19 cases preventively vaccinated with mumps‐measles‐rubella vaccine: all mild courseThus, with the here presented cases we support the AMS declaration that MMR vaccination, a...
-
Successful containment of COVID‐19 outbreak in a large maternity and perinatal center while continuing clinical serviceApart from massive testing of personnel in predefined phases and increased hygiene measure...
Show more Covid-19 (6)Show Less-
Website
Collapse
-
Successful subcutaneous desensitization to Dupilumab
-
Sublingual versus subcutaneous immunotherapy: a retrospective study among paediatric patients
-
Induction of type IV hypersensitivity in a red tattoo induced by subcutaneous immunotherapy: a case report
-
Rapid subcutaneous desensitization for the management of delayed hypersensitivity reactions to mepolizumab:A case report
-
The induction of IL-10 producing B regulatory cells leads to immunotolerance recovery with grass pollen subcutaneous immunotherapy
-
Safety of subcutaneous and sublingual immunotherapy with carbamylated monomeric allergoids in children: a real-life pharmacovigilance study
-
Characterizing clinically "relevant" and "irrelevant" adverse reactions to immunotherapy with subcutaneous polymerized house dust mite extracts
-
A randomized, double-blind placebo-controlled phase III study with mannan-conjugated birch pollen allergoids administered subcutaneously to allergic patients
-
Long-term efficacy and safety of subcutaneous garadacimab for prophylaxis of hereditary angioedema attacks: Results from a multicentre phase 3 study and open-label extension
-
Accelerated dose escalation scheme with 6 injections of an unmodified house dust mite (HDM) subcutaneous AIT (SCIT) preparation is safe and well tolerated in adolescents and adults
-
Correlation between CSMS and RQLQ in grass pollen induced seasonal allergic rhinitis/rhinoconjunctivitis after treatment with a modified grass allergen subcutaneous immunotherapy product
-
Correlation between CSMS and RQLQ in grass pollen induced seasonal allergic rhinitis/rhinoconjunctivitis after treatment with a modified grass allergen subcutaneous immunotherapy product
-
Adherence to pre-seasonal short-term subcutaneous immunotherapy versus perennial sublingual immunotherapy over 3 years of treatment: real-world data for MCT (MicroCrystalline Tyrosine) associated pollen allergoids
-
Short-course subcutaneous pre-seasonal treatment with a 13-grass pollen allergoid reduces allergy symptoms and relief medication use in allergic rhinitis: A randomised, double-blind, placebo-controlled adaptive trial. Speaker: Mohamed Shamji
-
Subcutaneous immunotherapy in an 89-year-old patient: a case report
-
Case Report of Real-World Use of human-sIRA 10% through Subcutaneous Infusion
-
Retrospective Review of the Pollen Subcutaneous Immunotherapy Service at Sheffield Children’s Hospital
-
Case Report: Use of Prophylactic Subcutaneous C1 Esterase Inhibition for Hereditary Angioedema in Pregnancy
-
Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids – safety data from 3 sequential trials
-
Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids – clinical data from 3 sequential trials
-
Subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids – immunological data from 3 sequential trials
-
Test Mélanie
-
Infections
-
Infections
-
Discussion
-
Discussion
-
Discussion
-
Discussion
-
Panel Discussion
-
Panel discussion
-
Panel discussion
-
Panel discussion
-
Panel discussion
-
Pro-rebutal
-
Con-rebutal
-
Pro-rebutal
-
Con-rebutal
-
Summary and close
-
Presentation test
-
Presentation Test
-
Genomics and proteomics
-
Asthma
-
Discussion and Closing Remarks
-
Questions and discussion
-
Videos
-
Asthma
-
Oral Presentations
-
Pro-rebuttal
-
Con-rebuttal
-
Pro-rebuttal
-
Con-rebuttal
-
Asthma and comorbidities
-
Optimising outcomes: Panel discussion
-
Welcome and introductions
-
Welcome and introductions
-
Welcome and Introductions
-
Welcome and Introductions
-
Welcome and Introductions
-
Test Practice stage
-
Smartinhalers
-
Figures
-
Obesity
-
Ocular allergy
-
Ocular allergy
-
Questions and answers
-
Patient case outcomes
-
Questions and answers
-
Asthma 1
-
Asthma 1
-
Asthma 2
-
Asthma 2
-
Asthma 3
-
Asthma 3
-
Open discussion
-
FPIES Diagnosis
-
2023 and beyond
-
Discussion and Q&A
-
Hidden parasitic causes in chronic spontaneous urticaria
-
Pollutants and Smoking
-
Severity and prognosis
-
Asthma phenotypes in children
-
Breast-feeding and maternal exposure
-
MP couple
-
Treasurer report
-
Practice Stage 2
-
Immunomodulation and nutrition
-
Immunomodulation and nutrition
-
Immuno-nutrition
-
Flash talks on genomics and proteomics
-
Allergy to anticonvulsant drugs
-
Comorbidities and complications
-
Welcome and Introduction
-
Welcome and Introduction
-
Welcome and introduction
-
Welcome and Introduction
-
Welcome and introduction
-
Welcome and introduction
-
Welcome and introduction
-
Allergy asthma and sport
-
Closing statement
-
Allergy to drugs?
-
Closing statement
-
Q&A and close
-
Test Presentation
-
Test presentation
-
Test Presentation
-
Test Presentation
-
Conclusion
-
Immunology
-
Aerobiology and pollution
-
Follicular T helper cells
-
Lessons learned from COPD
-
Unmet needs in AIT
-
Exhaled Biomarkers
-
Viral infections and vaccinations
-
T2 immune response
-
Inborn errors of immunity: an expanding universe
-
FPIES Pathogenesis
-
Sponsored session Nutricia Danone
-
Epicutaneous Immunotherapy for peanut allergy: an update
-
Panel Discussion / Q&A
-
Management of drug allergy
-
Asma grave no pré escolar
-
Session 3: Practical management in adult patients
-
Poster presentation
-
Poster presentation
-
Poster presentation
-
Summary & Close
-
Poster presentation
-
Poster presentation
-
Poster presentation
-
Poster presentation
-
Poster presentation
-
Poster presentation
-
Aerobiology and pollution 1
-
Biologics in ocular Allergy
-
Question and Answer Session
-
Mastocytosis and mast cells
-
Mastocytosis and mast cells
-
Aerobiology and pollution 2
-
Dietary management of FPIES
-
Which skin tests can be used for delayed cutaneous adverse drug reactions?
-
Which skin tests can be used for delayed cutaneous adverse drug reactions?
-
Interactive expert panel discussion
-
Interactive expert panel discussion
-
Interactive expert panel discussion
-
Dupilumab for cancer-associated refractory pruritus
-
Introduction
-
Q&A and panel discussion
-
Panel Discussion and Q&A
-
CSN5 is a circulating marker for asthma exacerbation
-
Exercise-induced Asthma: What's new?
-
Introduction
-
Q&A and panel discussion
-
EAACI Official Video
-
Allergic rhinitis and asthma
-
Introduction
-
Introduction
-
Urticaria: still unmet needs
-
Introduction
-
Drug allergy
-
A case of macrolides-induced Acute Localized Exanthematous Pustulosis (ALEP)
-
Epithelial derived cytokines
-
Pro - static
-
Introduction
-
Exercise-induced anaphylaxis
-
Uncovering Drug-Induced Cutaneous Vasculitis: A 19-Year Study
-
Audit report and reappointment of the Auditor
-
From climate change to sensitisation patterns
-
Functional and Inflammatory diagnostic tools
-
Airpollution and respiratory diseases
-
Post orgasmic illness syndrome (POIS)
-
What's new in the Gut
-
Put a ring on it? When the ring is not what you wished
-
Flash talks on asthma
-
Test session Industry
-
Opening video
-
Opening video
-
Panel Q&A
-
Opening video
-
Researcher & Clinician perspective
-
Opening video
-
Opening video
-
Meeting close
-
Immunotherapy
-
Opening video
-
Opening video
-
Opening video
-
Meeting close
-
Opening video
-
Asthma exacerbation or something else?
-
Is GINA Step 1 and Step 2 mild astham?
-
Effect of pollution and environmental stress in allergy
-
Panel discussion and questions
-
Management of pediatric asthma
-
Leukocytoclastic vasculitis caused by iodixanol
-
Food Insecurity in Children and Adults With Food Allergy
-
Spain
-
Flash talks on immune-mediated diseases
-
Lunch
-
IgA and gut microbiota- the importance of being specific
-
A case of recurrent severe anaphylaxis linked to breeding pigeons
-
Clinical Relevance of Serum CC16 in Adult Asthma
-
Q&A and concluding comments
-
Etiology and comorbidity of chronic spontaneous urticaria
-
Functional analysis of phospholipase A2 mouse model of anaphylaxis
-
Functional analysis of phospholipase A2 mouse model of anaphylaxis
-
Insect venom allergy in a time of change
-
United Kingdom
-
Award Ceremony
-
Drug allergy 1
-
Drug allergy 1
-
Drug allergy 2
-
Drug allergy 2
-
Aquagenic urticaria: Case report and mini-review of the literature
-
Omalizumab updosing in Chronic Spontaneous Urticaria non-responder patients
-
Tissue-specific immune responses at barrier sites
-
IgG-induced nPutrophil activation and anaphylaxis
-
Flash talks on COVID 19
-
JMA Poster presentation
-
Flash talks on exposome
-
Atopy and Mental Health
-
How to manage a patient with EoE
-
How to manage a patient with EoE
-
EAACI Global Stage: East vs West
-
Immunomodulatory strategies for:
-
Omics to define allergy severity
-
Asma grave: malattia o sindrome?
-
Non-allergic rhinitis and asthma
-
Flash talks on rhinits and rhinosinusitis
-
Looking at ocular allergy with other eyes
-
Allergists and EoE: Supporting the Patient Journey
-
Allergen-specific B cell tolerance in food allergy
-
Hypersensitivity to excipients in vaccines
-
Regulatory issues of AIT
-
Skin microbiota-host interactions
-
Flecainide induced maculopapular exanthema
-
What birth cohorts have taught us recently
-
Q&A Session
-
Flash talks on urticaria
-
Oncostatin M promotes sensory nerve fiber outgrowth
-
Adverse drug reactions in a regional hospital in Jeju, Korea
-
Flash talks on asthma II
-
Allergy to pets
-
Pulmonary Function Tests
-
Asthma pheno-endotyping for experts Part 1
-
Asthma pheno-endotyping for experts Part 2
-
Resolution: beyond asthma control
-
Inborn errors of immunity with atopic manifestations
-
Tropomyosin, an important mealworm allergen
-
Paracetamol induced glove and sock syndrome
-
Registry-based randomized controlled trials
-
Asthma endotypes: static or fluid entities?
-
Introduction and Patient Testimony
-
Targeting eosinophilic esophagitis
-
Egg allergy debut in adult patient
-
Adherence and inhalation technique
-
What's new in the Airways
-
Interleukin 33 and asthma
-
Flash talks on angioedema
-
Defining super-responders
-
Diagnosis of food allergy
-
Atezolizumab and Bevacizumab. Who is guilty?
-
Education and self-management of anaphylaxis
-
New discoveries in IgE-mediated autoimmunity
-
FPIES Management
-
The Specialised Nutrition Europe initiatives
-
Influence of global climate change on Hymenoptera distribution.
-
Association of early antimicrobial use with allergy development
-
Peanut challenges in young children
-
Is major allergen content relevant?
-
Meet and greet the EAACI Leadership
-
Real-life data in allergic diseases
-
Anti-alarmins and airway remodeling
-
Diagnostic criteria for acute FPIES
-
Pediatric post-covid manifestations
-
A case report of cvid associated granulomatous disease
-
The spectrum of severity in food allergy: state of art
-
Epidermal Langerhans cells
-
Welcome
-
Pretest
-
Pretest
-
Welcome
-
Romania
-
Germany
-
Flash talks on anaphylaxis
-
Welcome
-
Secretary General and Vice-Presidents reports
-
Prevalence and phenotypes of pediatric asthma
-
Welcome
-
Welcome
-
Welcome
-
Welcome
-
Group A
-
Group B
-
Group C
-
Group D
-
Group A
-
Group B
-
Group C
-
Group D
-
Historical overview: what happened up to 2022
-
Welcome
-
Can we prevent food allergy through the skin?
-
Disease burden assessment and unmet medical need in ISM
-
AllergoOncology: Why IgE can be good
-
Management of FPIES: the usual and the unusual
-
Can MAT beat BAT?
-
Cow´s milk oral immunotherapy, our experience
-
mRNA platforms -
-
Keynote Lecture 1
-
Atopic dermatitis
-
Keynote Lecture 2
-
Keynote Lecture 3
-
Interactive cases
-
Occupational asthma endotyping: the past and the future.
-
A critical review of efficacy outcomes used in food AIT,
-
Mission cat allergy: How to diagnose and manage patients
-
Q&A and Closing remarks
-
Flash talks on food allergy
-
Papel de las citocinas epiteliales en la respuesta inmune del asma
-
Multidimensional endotyping
-
Poster discussion session 1
-
Poster discussion session 2
-
Poster discussion session 3
-
Poster discussion session 4
-
Poster discussion session 5
-
Poster discussion session 6
-
Use of Molecular IgE diagnostics in food and respiratory allergies
-
Closing Ceromony and awards
-
Autoimmunity mediated by IgE autoantibodies in chronic spontaneous urticaria
-
European Medicines Agency perspective
-
Molecular diagnosis in animal allergy
-
Session 2: Current Guidelines in CSU Management
-
Safety and prediction of allergen immunotherapy
-
Local respiratory allergy and allergic rhinitis
-
From preschool wheezing to asthma: determinants
-
Coexposure to allergens and proteases in salmon industry workplaces
-
Classical treatment approaches and the emerging role of biologicals
-
Investigating the diagnostic value of histamine for perioperative anaphylaxis
Show more Sessions (338)Show Less-
-
Cristiano Caruso
-
Cristiano Caruso
-
Stefanie Busold
-
Ruchi Gupta
-
Juan Urrego
-
Christian Neuhof
-
Urban Cerpes
-
Jean Bousquet
-
Sebastian Johnston
-
Stefan Vieths
-
Luciana Tanno
-
Orianne Dumas
-
George Konstantinou
-
Stephane Hazebrouck
-
Stephanie Korn
-
Katherine Pose
-
Oscar Calderon
-
Yuzaburo Inoue
-
Cristina Lopes
-
Janne Goossens
-
Constantinos Pitsios
-
Narissara Suratannon
-
Oscar Palomares
-
Aneta Krogulska
-
Tsung-Chieh Yao
-
Giulia Costanzo
-
Tetiana Umanets
-
Julia Zarnowski
-
Stacey Maudsley
-
Stefan Beissert
-
Ourania Kotsiou
-
Patricia Gutierrez Canales
-
Jisun Yoon
-
Lars Lange
-
Subir Jain
-
Konstantina Dimitriou
-
Steilos Loukidis
-
Roberta Scarpone
-
Cristian Condack
-
Christian Woehlk
-
Cristiano Garino
-
Rosa Muñoz-Cano
-
Eleni Anastasiou
-
Victoria Soriano
-
Martine Morisset
-
Kęstutis Černiauskas
-
Anastasios Constantinopoulos
-
Carla Jones
-
Rosan Meyer
-
Mingtao Liu
-
Joana Cosme
-
Isabel Rojo
-
Jiung Jeong
-
Rosan Meyer
-
Yasutaka Mitamura
-
Harshita Shailesh
-
Marcello Albanesi
-
Giovanni Costanzo
-
Cristina Cacheiro
-
Christina Polasky
-
Christian Lupinek
-
Christiane Hilger
-
Marcello Albanesi
-
Stephanie Dramburg
-
Antonio Spanevello
-
Jose Luis Garcia-Abujeta
-
Jonathan Bernstein
-
Mare Lõhmus
-
Gunter Sturm
-
Cristina De Castro
-
Stefano Turillazzi
-
Sanghwa Youm
-
Katsumasa Kitamura
-
Rand Arnaout
-
Elisabeth Laderman
-
Stefano Forestieri
-
Jonas Lander
-
Hui-Fang Kao
-
Eman Alfares
-
Marco Cinquantasei
-
Svitlana Zubchenko
-
Victoria Hinkkanen
-
Shuo-Yan Gau
-
Stefan Frent
-
Natasa Kusic
-
Janet Davies
-
Riccardo Castagnoli
-
J Christian Virchow
-
Urszula Radzikowska
-
Alessandra De Conti
-
Stefania Colantuono
-
Christian Vogelberg
-
Aleksandra Likonska
-
Sonya Vysochanskaya
-
Emma Guttman-Yassky
-
Naphisabet Wanniang
-
Luca Richeldi
-
Ruby Pawankar
-
Jane McDowell
-
Marc Vocanson
-
Monique Butze
-
Lucia Pacillo
-
Juan Trujillo
-
Stefan Aigner
-
Miu Nam Yeung
-
Roberta Zunno
-
Hitomi Kubota
-
Mariana Couto
-
Tuğba Güler
-
Kyunguk Jeong
-
Eun Hee Chung
-
Stefan Zielen
-
Luca Lo Sardo
-
Arzu Bakirtas
-
Jeroen Buters
-
Heung-Man Lee
-
Yuma Fukutomi
-
Stephan Gabet
-
Polliana Leru
-
Nico Janssens
-
Fabiana Furci
-
Juan Carlos Miralles
-
Supaluk Tangvalelerd
-
Norbert Mülleneisen
-
Ismael Garcia-Moguel
-
Nikitas Sidiropoulos
-
Oscar Correa-Jimenez
-
Stefania Arasi
-
Fabio Candotti
-
Adnan Custovic
-
Mubeccel Akdis
-
Eva Untersmayr
-
Ümit şahiner
-
Riccardo Asero
-
Esther Raskopf
-
Gabija Biliute
-
Byung-Keun Kim
-
Jacquie Badiou
-
Francesca Mori
-
Atsuhito Nakao
-
Beatrice Aiuto
-
Ting Fan Leung
-
Daniele Quarta
-
Tuğba Önalan
-
Koichiro Asano
-
Ishino Takashi
-
Eva Untersmayr
-
Luca Cavalieri
-
Isabelle Meyts
-
Isabelle Meyts
-
Francesca Mori
-
Mubeccel Akdis
-
Jose Lopes dos Santos
-
Ismael García Moguel
-
Tushar Kanti Banerjee
-
Christian Apfelbacher
-
Constanze A. Jakwerth
-
Hulya Ercan Saricoban
-
Yoon Heo
-
Michael Rudenko
-
Ferdaous Chahed
-
Marcin Kurowski
-
Gohar Tsakanova
-
Paula Gutierrez
-
Giselle Mosnaim
-
Christina Bauer
-
Julie Riechmann
-
Nuria Contreras
-
Kristina Rueter
-
Franca Ronchese
-
Saintedym Wills
-
Johannes Schmid
-
Selene Nicolosi
-
Lucija Markovic
-
Matthew Burgess
-
Joanna Makowska
-
Oksana Matsyura
-
Aseel Almasoudi
-
Vanessa Granger
-
Roberta Massaro
-
Natcha Manasilp
-
Tatsuo Horiuchi
-
Roberta Parente
-
Ricardo Zwiener
-
Stefano Palazzo
-
Yvan Vandenplas
-
Hania Szajewska
-
Daniela Brandão Abreu
-
Alba Sánchez Montalvo
-
Lucía Cremades-Jimeno
-
Eva Gomes
-
Isabella Annesi-Maesano
-
Michael Wechsler
-
Ratko Djukanovic
-
Sonsoles Infante
-
Marek Lommatzsch
-
Uta Jappe
-
Daniela Carvalho
-
Lawrence DuBuske
-
Isadora Francescantonio
-
Caroline Nilsson
-
Alicia Moncada Salinero
-
Jonathan Spergel
-
Hanna Mayerhofer
-
Grainne Cunniffe
-
Khuloud Alsehaim
-
Michael Gerspach
-
Christine Hafner
-
Josefien Vandekerckhove
-
Marta Lomikovska
-
Dragan Mijakoski
-
Paloma Carinanos
-
Xueyi Zhu
-
Suzana Radulovic
-
Eugenio De Corso
-
Javier Dominguez
-
Martin Steinhoff
-
Luo Zhang
-
Francesca Perego
-
Márcia Quaresma
-
Antonella Muraro
-
Annelie Turesson
-
Jettanong Klaewsongkram
-
Emmanouela Sdona
-
Jitka Smetanová
-
Vibeke Østberg Landaas
-
Joana Guimarães
-
Can Tuzer
-
Masataka Suehiro
-
Caroline Beutner
-
Yidan Sun
-
Maria Otal-Buesa
-
Nelly Catalán Cáceres
-
Foteini Kapsouli
-
Jan Witte
-
Julijana Asllani
-
Cláudia Chaves Loureiro
-
Sayantani Sindher
-
Francesco Cinetto
-
Carmen Panaitescu
-
Florence Roufosse
-
Stephan Weidinger
-
Torsten Zuberbier
-
Isabella Badolati
-
Célia M. Antunes
-
Galyna Yeryomenko
-
Mohamed Abuzakouk
-
Yoshitaka Okamoto
-
Martina Berchtold
-
Laurence Bouillet
-
Tamazoust Guiddir
-
Hisanori Hirokawa
-